These findings suggest that recent cohorts of adolescent girls are experiencing increases in internalizing symptoms compared to previous cohorts. Approaches for prevention and early intervention should be explored.
Three variants of a behavioral family intervention (BFI) program known as Triple P were compared using 305 preschoolers at high risk of developing conduct problems. Families were randomly assigned to enhanced BFI (EBFI), standard BFI (SBFI), self-directed BFI (SDBFI), or wait list (WL). At postintervention, the 2 practitioner-assisted conditions were associated with lower levels of parent-reported disruptive child behavior, lower levels of dysfunctional parenting, greater parental competence, and higher consumer satisfaction than the SDBFI and WL conditions. Overall, children in EBFI showed greater reliable improvement than children in SBFI, SDBFI, and WL. By 1-year follow-up, children in all 3 conditions achieved similar levels of clinically reliable change in observed disruptive behavior. However, the EBFI and SBFI conditions showed greater reliable improvement on parent-observed disruptive child behavior.
The relationships between severity, chronicity, and timing of maternal depressive symptoms and child outcomes were examined in a cohort of 4,953 children. Mothers provided selfreports of depressive symptoms during pregnancy, immediately postpartum, and when the child was 6 months old and 5 years old. At the age 5 follow-up, mothers reported on children's behavior and children completed a receptive vocabulary test. Results suggest that both the severity and the chronicity of maternal depressive symptoms are related to more behavior problems and lower vocabulary scores in children. The interaction of severity and chronicity of maternal depressive symptoms was significantly related to higher levels of child behavior problems. Timing of maternal symptoms was not significantly related to child vocabulary scores, but more recent reports of maternal depressive symptoms were associated with higher rates of child behavior problems.Many studies have documented the association between maternal depression and adverse outcomes in children. Studies with clinical samples of depressed parents, focused primarily on mothers, have shown elevated rates of depression in children as well as anxiety and disruptive behavior disorders (reviewed in Downey & Coyne, 1990;Hammen, 1999). Studies with community samples of women with self-reported symptoms of depression have also shown adverse outcomes in children. These latter studies included infants, toddlers, and children of varying ages, and virtually all measures of the children's affect and behaviors showed evidence of maladaptive reactions to their mothers' dysphoria (reviewed in Downey & Coyne;Gelfand & Teti, 1990).The consistency of detrimental effects across numerous samples and methodologies has doubtless suggested that maternal depressive symptoms invariably have a negative impact on children's behavior. However, most of the studies have been cross-sectional in design, and they provide little information about the nature of maternal depression and how often it leads to problems for children. Depression is extremely heterogeneous in its manifestations, ranging from mild and transitory mood distress that is entirely normal to persisting and severe
Mothers differ systematically from their children when they are reporting their child's behaviour (mental health). The more emotionally impaired the mother, the greater the degree to which she imputes the child to have behaviour problems. Further, female children are attributed to have more internalising behaviours and male children externalising behaviours.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.